Uss Investment Management LTD Neurocrine Biosciences Inc Transaction History

Uss Investment Management LTD

  • $13.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$75.79 - $100.07 $103,680 - $136,895
-1,368 Reduced 16.31%
7,018 $684,000
Q1 2022

May 13, 2022
SELL
$72.45 - $94.81 $895,554 - $1.17 Million
-12,361 Reduced 59.58%
8,386 $787,000
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $1.32 Million - $1.52 Million
15,312 Added 281.73%
20,747 $1.99 Million
Q2 2020

Aug 11, 2020
BUY
$85.09 - $130.36 $462,464 - $708,506
5,435 New
5,435 $663,000

Others Institutions Holding NBIX

# of Institutions
627
Shares Held
94M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Uss Investment Management LTD Portfolio

Follow Uss Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email